Central Nervous System Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 3
Author(s): Gian Luigi Mariottini
Affiliation:
Export Options
About this article
Cite this article as:
Mariottini Luigi Gian , Meet Our Editorial Board Member, Central Nervous System Agents in Medicinal Chemistry 2017; 17 (3) . https://dx.doi.org/10.2174/187152491703171025125402
DOI https://dx.doi.org/10.2174/187152491703171025125402 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Beyond The Therapeutic Effect of rTMS in Alzheimer’s Disease: A Possible Neuroprotective Role of Hippocampal BDNF? : A Minireview
Mini-Reviews in Medicinal Chemistry Glucocorticoid Regulates Parkin Expression in Mouse Frontal Cortex: Implications in Schizophrenia
Current Neuropharmacology Proteolytic Cleavage of Notch: “HIT and RUN”
Current Molecular Medicine The Anabolic Androgenic Steroid Testosterone Propionate Decreases Recognition Memory in Adult Male Rats
Current Psychopharmacology Editorial [Hot Topic: Youth at Risk for Psychosis (Guest Editors: Steven Adelsheim and David Graeber)]
Adolescent Psychiatry Neuroprotective Appraisal of Methanolic Extract of Flowers of Nerium oleander in a Non Classical Rat Model of Alzheimer Disease
The Natural Products Journal Paranoigenic Extremes - a Reappraisal Concerning Paranoid Personality Disorder
Current Psychiatry Reviews Users Perception of Risk and Benefits of Mood Modifying Drugs
Current Clinical Pharmacology Cell Culture Models of Oxidative Stress and Injury in the Central Nervous System
Current Neurovascular Research Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Current Pharmaceutical Design Pharmacologic Evidence of Green Tea in Targeting Tyrosine Kinases
Current Reviews in Clinical and Experimental Pharmacology The Role of Advanced Technologies Supplemented with Traditional Methods in Pharmacovigilance Sciences
Recent Patents on Biotechnology In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer’s Disease Therapy
Current Computer-Aided Drug Design Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology The TT allele of rs405509 synergizes with APOE ε4 in the impairment of cognition and its underlying default mode network in non-demented elderly
Current Alzheimer Research Bioaccessibility of Bioactive Compounds and Prebiotic Properties of Fruit and Vegetable By-products - A Mini Review
Current Bioactive Compounds Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics
Current Pharmaceutical Design Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Central Nervous System Agents in Medicinal Chemistry Neurological Disorder Drug Discovery from Gene Expression with Tensor Decomposition
Current Pharmaceutical Design Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets